Opportunity for Public Comment - US Preventive Services Task Force

Opportunity for Public Comment - US Preventive Services Task Force

Draft Research Plan: Aspirin Use to Prevent Preeclampsia

Public Comment on Draft Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality The U.S. Preventive Services Task Force posted today a draft research plan on aspirin use to prevent preeclampsia and related morbidity and mortality. The draft research plan is available for review and public comment from June 20, 2019 through July 17, 2019. To review the draft research plan and submit comments, go here. This Draft Research Plan Is Open to Public Comments

COMMENTING DETAILS

Commenting Window: 6/20/19 - 7/17/19 Any visitor to the Task Force Web site can comment on any of the listed USPSTF draft documents. However, readers should note that the USPSTF writes these documents for researchers, primary care doctors, and other health care providers, using medical and scientific language as appropriate for these audiences. Learn more about the process.

WHERE WE ARE IN THE PROCESS

Draft Research Plan Final Research Plan Draft Recommendation Statement / Draft Evidence Review Final Recommendation Statement / Evidence Summary